Sales by business segment
| 2020/2021 evolution | |||||
|---|---|---|---|---|---|
| € millions | 2019 | 2020 | 2021 | Like-for-like | Reported figures |
| Skincare | 10,453 | 11,052 | 12,982 | 17.7% | 17.5% |
| Make-up | 7,854 | 5,969 | 6,627 | 13.1% | 11.0% |
| Haircare | 4,461 | 4,254 | 4,880 | 16.7% | 14.7% |
| Hair colourants | 3,032 | 2,972 | 3,016 | 3.6% | 1.5% |
| Perfumes | 2,771 | 2,529 | 3,512 | 34.5% | 38.9% |
| Other(1) | 1,303 | 1,216 | 1,271 | 4.3% | 4.4% |
| TOTAL COSMETICS SALES | 29,874 | 27,992 | 32,288 | 16.1% | 15.3% |
Compared consolidated income statements
| € millions | 2021 | 2020 | 2019 |
|---|---|---|---|
| Net sales | Net sales202132,287.6 | Net sales202027,992.1 | Net sales201929,873.6 |
| Cost of sales |
Cost of sales 2021-8,433.3 |
Cost of sales 2020-7,532.3 |
Cost of sales 2019-8,064.7 |
| Gross profit | Gross profit202123,854.3 | Gross profit202020,459.8 | Gross profit201921,808.9 |
| Research & Innovation expenses |
Research & Innovation expenses 2021-1,028.7 |
Research & Innovation expenses 2020-964.4 |
Research & Innovation expenses 2019-985.3 |
| Advertising and promotion expenses |
Advertising and promotion expenses 2021-10,591.0 |
Advertising and promotion expenses 2020-8,647.9 |
Advertising and promotion expenses 2019-9,207.8 |
| Selling, general and administrative expenses |
Selling, general and administrative expenses 2021-6,074.2 |
Selling, general and administrative expenses 2020-5,638.5 |
Selling, general and administrative expenses 2019-6,068.3 |
| Operating profit | Operating profit20216,160.3 | Operating profit20205,209.0 | Operating profit20195,547.5 |
| Other income and expenses |
Other income and expenses 2021-432.0 |
Other income and expenses 2020-709.0 |
Other income and expenses 2019-436.5 |
| Operational profit | Operational profit20215,728.3 | Operational profit20204,500.0 | Operational profit20195,111.0 |
| Finance costs on gross debt |
Finance costs on gross debt 2021-38.0 |
Finance costs on gross debt 2020-79.2 |
Finance costs on gross debt 2019-75.4 |
| Finance income on cash and cash equivalents |
Finance income on cash and cash equivalents 202118.5 |
Finance income on cash and cash equivalents 202019.8 |
Finance income on cash and cash equivalents 201928.7 |
| Finance costs, net | Finance costs, net2021-19.4 | Finance costs, net2020-59.4 | Finance costs, net2019-46.7 |
| Other financial income and expenses |
Other financial income and expenses 2021-40.2 |
Other financial income and expenses 2020-36.5 |
Other financial income and expenses 2019-16.0 |
| Sanofi dividends |
Sanofi dividends 2021378.3 |
Sanofi dividends 2020372.4 |
Sanofi dividends 2019363.0 |
| Profit before tax and associates | Profit before tax and associates20216,046.9 | Profit before tax and associates20204,776.5 | Profit before tax and associates20195,411.4 |
| Income tax |
Income tax 2021-1,445.4 |
Income tax 2020-1,209.8 |
Income tax 2019-1,657.2 |
| Share of profit in associates |
Share of profit in associates 20210.6 |
Share of profit in associates 20200.9 |
Share of profit in associates 20191.0 |
| Net profit | Net profit20214,602.2 | Net profit20203,567.6 | Net profit20193,755.2 |
| Attributable to: |
Attributable to: 2021
|
Attributable to: 2020
|
Attributable to: 2019
|
|
4,597.1 |
3,563.4 |
3,750.0 |
|
5.1 |
4.2 |
5.2 |
| Earnings per share attributable to owners of the company (euros) |
Earnings per share attributable to owners of the company ( euros) 20218.24 |
Earnings per share attributable to owners of the company ( euros) 20206.37 |
Earnings per share attributable to owners of the company ( euros) 20196.70 |
| Diluted earnings per share attributable to owners of the company (euros) |
Diluted earnings per share attributable to owners of the company ( euros) 20218.21 |
Diluted earnings per share attributable to owners of the company ( euros) 20206.34 |
Diluted earnings per share attributable to owners of the company ( euros) 20196.66 |
| Earnings per share attributable to owners of the company, excluding non-recurring items (euros) |
Earnings per share attributable to owners of the company, excluding non-recurring items (euros)20218.86 |
Earnings per share attributable to owners of the company, excluding non-recurring items (euros)20207.33 |
Earnings per share attributable to owners of the company, excluding non-recurring items (euros)20197.78 |
| Diluted earnings per share attributable to owners of the company, excluding non-recurring items (euros) |
Diluted earnings per share attributable to owners of the company, excluding non-recurring items ( euros) 20218.82 |
Diluted earnings per share attributable to owners of the company, excluding non-recurring items ( euros) 20207.30 |
Diluted earnings per share attributable to owners of the company, excluding non-recurring items ( euros) 20197.74 |
Sources and application of funds
This graph shows the sources and applications funds
| Sources | |
|---|---|
| Net profit attributable to owners of the company | 4,602.2 |
| Amortisation and provisions | 1,781.0 |
| Capital gain or losses on disposals of assets, changes in deferred taxes and other | 257.2 |
| Applications | |
| Investments in tangible and intangible assets | 1,075.2 |
| Operating cash flow | 5,653.2 |
| Changes in working capital requirement | -88 |
| Gross cash flow: | 6,640.4 |